Transcatheter Embolization of Renal Cell Carcinoma with I-125 Particles

  • E. K. Lang
Conference paper
Part of the Radiology Today book series (RADIOL.TODAY, volume 3)


Transcatheter embolization of renal cell carcinomas with radioactive infarct particles is undertaken to create an interstitial implant capable of delivering a tumoricidal dose to the neoplasm. This modality is advocated for the treatment of inoperable renal cell carcinoma or renal cell carcinoma in a solitary or remaining kidney, management of metastases of renal cell carcinoma, and downstaging of inoperable lesions in the hope of converting them into operable ones [1–4].


Renal Cell Carcinoma Advanced Renal Cell Carcinoma Transcatheter Embolization Muscular Branch Radioactive Seed 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lang EK, Sullivan J, DeKernion JB (1983) Work in progress: transeatheter embolization of renal cell carcinoma with radioactive infarct particles. Radiology 147: 413–418PubMedGoogle Scholar
  2. 2.
    Lang EK, DeKernion JB (1981) Transeatheter embolization of advanced renal cell carcinoma with radioactive seeds. J U 126: 581–586Google Scholar
  3. 3.
    Lang EK (1984) Transeatheter embolization of renal cell carcinoma with radioactive infarct particles. In: Libertino JA (ed) Current concepts of uro- radiology. Williams and Wilkins, Baltimore, pp 226–236Google Scholar
  4. 4.
    Lang EK (1971) Superselective arterial catheterization as vehicle for delivering radioactive infarct particles to tumors. Radiology 98: 391–399PubMedGoogle Scholar
  5. 5.
    Droller MJ, Levy H J (1984) Immuno therapy of metastatic renal cell carcinoma with poly IC LC. 79th annual meeting of the American urologie association, paper # 301, may 6–10Google Scholar
  6. 6.
    Ling CC, Yorke ED, Spiro IG et al. (1978) Physical dosimetry of 1-125 seeds of a new design for in-terstitial implant. NCRP publication CA 30378Google Scholar
  7. 7.
    Skinner DJ, DeKernion JB (1978) Clinical manifestations and treatment of renal parenchymal tumors. In: Skinner DJ, DeKernion JB (eds) Genitourinary Cancer. Saunders, Philadelphia, pp 107–133Google Scholar
  8. 8.
    Katz SA, Davis JE (1977) Renal adenocarcinoma: prognostics and treatment reflected by survival. Urology 10: 10–19PubMedCrossRefGoogle Scholar
  9. 9.
    Bloom HJG (1973) Hormone induced and spontaneous regression of metastatic renal cancer. Cancer 32: 1066–1071PubMedCrossRefGoogle Scholar
  10. 10.
    Bloom HJG (1973) Adjuvant therapy for adenocarcinoma of the kidney, present position and prospects. Br J Urol 45: 237–245PubMedCrossRefGoogle Scholar
  11. 11.
    DeKernion JB, Katsuoka Y, Ramming KP (1980) Immunology of human renal adenocarcinoma. In: Sufrin G, Beckley SA (eds) Renal adenocarcinoma: a series of workshops on the biology of human cancer. International Union Against Cancer, Geneva, pp 96–113 (report 10 )Google Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1985

Authors and Affiliations

  • E. K. Lang

There are no affiliations available

Personalised recommendations